Physician profile
John Boone
NPI 1578950044
$69,910.56
in general payments reported to CMS, 2019-2025
27 companies · $50K in 2025
The $50K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $385 · 2021: $3,218 · 2022: $3,219 · 2023: $6,802 · 2024: $6,372 · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $13K · Travel and Lodging: $3,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,627.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,600.00 |
| Food and Beverage | $13,156.69 |
| Travel and Lodging | $3,703.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $31,011.81 | 2020-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $10,504.59 | 2024-2025 | |
| Abbvie INC. | $7,647.55 | 2020-2025 | Rinvoq, Skyrizi, Humira |
| Janssen Scientific Affairs, LLC | $6,299.75 | 2025 | Tremfya |
| Amgen INC. | $3,293.13 | 2020-2025 | Krystexxa, Enbrel, Tavneos |
| Janssen Biotech, INC. | $2,685.38 | 2024-2025 | Tremfya, Simponi Aria |
| Horizon Therapeutics Plc | $2,282.44 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,061.04 | 2021-2025 | Saphnelo |
| Mallinckrodt Hospital Products INC. | $968.26 | 2021-2025 | Acthar |
| E.R. Squibb & Sons, L.L.C. | $781.33 | 2020-2025 | Orencia |
| Pfizer INC. | $773.92 | 2021-2025 | |
| Glaxosmithkline, LLC. | $508.14 | 2020-2025 | Benlysta, Nucala |
| Lilly USA, LLC | $412.06 | 2022-2024 | Taltz |
| Genzyme Corporation | $399.07 | 2020-2025 | |
| Alexion Pharmaceuticals, INC. | $264.08 | 2022-2025 | Strensiq |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $227.85 | 2024-2025 | Hyrimoz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.66 | 2021-2025 | Ofev, Cyltezo |
| Aurinia Pharma U.S., INC. | $139.42 | 2022-2024 | Lupkynis |
| Organon LLC | $125.73 | 2023-2025 | Hadlima, Renflexis |
| Sobi, INC | $108.17 | 2023-2025 | |
| Radius Health, INC. | $55.59 | 2023-2025 | Tymlos |
| Genentech USA, INC. | $32.85 | 2024 | Actemra |
| Actelion Pharmaceuticals US, INC. | $32.55 | 2025 | Uptravi |
| United Therapeutics Corporation | $26.98 | 2024 | Tyvaso |
| Kiniksa Pharmaceuticals International, Plc | $16.82 | 2024 | Arcalyst |
| Celgene Corporation | $15.11 | 2021 | |
| Hikma Pharmaceuticals USA | $13.28 | 2023 | Mitigare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.